iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis
Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred from a set of active compounds that were acquired experimentally. Moreover, most docking programs loosely coupled the stages (binding-site and ligand pre...
Saved in:
| Published in: | BMC bioinformatics Vol. 12 Suppl 1; no. S1; p. S33 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
BioMed Central
15-02-2011
BioMed Central Ltd BMC |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred from a set of active compounds that were acquired experimentally. Moreover, most docking programs loosely coupled the stages (binding-site and ligand preparations, virtual screening, and post-screening analysis) of structure-based virtual screening (VS). An integrated VS environment, which provides the friendly interface to seamlessly combine these VS stages and to identify the pharmacological interactions directly from screening compounds, is valuable for drug discovery.
We developed an easy-to-use graphic environment, iGEMDOCK, integrating VS stages (from preparations to post-screening analysis). For post-screening analysis, iGEMDOCK provides biological insights by deriving the pharmacological interactions from screening compounds without relying on the experimental data of active compounds. The pharmacological interactions represent conserved interacting residues, which often form binding pockets with specific physico-chemical properties, to play the essential functions of a target protein. Our experimental results show that the pharmacological interactions derived by iGEMDOCK are often hot spots involving in the biological functions. In addition, iGEMDOCK provides the visualizations of the protein-compound interaction profiles and the hierarchical clustering dendrogram of the compounds for post-screening analysis.
We have developed iGEMDOCK to facilitate steps from preparations of target proteins and ligand libraries toward post-screening analysis. iGEMDOCK is especially useful for post-screening analysis and inferring pharmacological interactions from screening compounds. We believe that iGEMDOCK is useful for understanding the ligand binding mechanisms and discovering lead compounds. iGEMDOCK is available at http://gemdock.life.nctu.edu.tw/dock/igemdock.php. |
|---|---|
| AbstractList | Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred from a set of active compounds that were acquired experimentally. Moreover, most docking programs loosely coupled the stages (binding-site and ligand preparations, virtual screening, and post-screening analysis) of structure-based virtual screening (VS). An integrated VS environment, which provides the friendly interface to seamlessly combine these VS stages and to identify the pharmacological interactions directly from screening compounds, is valuable for drug discovery. We developed an easy-to-use graphic environment, iGEMDOCK, integrating VS stages (from preparations to post-screening analysis). For post-screening analysis, iGEMDOCK provides biological insights by deriving the pharmacological interactions from screening compounds without relying on the experimental data of active compounds. The pharmacological interactions represent conserved interacting residues, which often form binding pockets with specific physico-chemical properties, to play the essential functions of a target protein. Our experimental results show that the pharmacological interactions derived by iGEMDOCK are often hot spots involving in the biological functions. In addition, iGEMDOCK provides the visualizations of the protein-compound interaction profiles and the hierarchical clustering dendrogram of the compounds for post-screening analysis. We have developed iGEMDOCK to facilitate steps from preparations of target proteins and ligand libraries toward post-screening analysis. iGEMDOCK is especially useful for post-screening analysis and inferring pharmacological interactions from screening compounds. We believe that iGEMDOCK is useful for understanding the ligand binding mechanisms and discovering lead compounds. iGEMDOCK is available at http://gemdock.life.nctu.edu.tw/dock/igemdock.php. Abstract Background Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred from a set of active compounds that were acquired experimentally. Moreover, most docking programs loosely coupled the stages (binding-site and ligand preparations, virtual screening, and post-screening analysis) of structure-based virtual screening (VS). An integrated VS environment, which provides the friendly interface to seamlessly combine these VS stages and to identify the pharmacological interactions directly from screening compounds, is valuable for drug discovery. Results We developed an easy-to-use graphic environment, iGEMDOCK, integrating VS stages (from preparations to post-screening analysis). For post-screening analysis, iGEMDOCK provides biological insights by deriving the pharmacological interactions from screening compounds without relying on the experimental data of active compounds. The pharmacological interactions represent conserved interacting residues, which often form binding pockets with specific physico-chemical properties, to play the essential functions of a target protein. Our experimental results show that the pharmacological interactions derived by iGEMDOCK are often hot spots involving in the biological functions. In addition, iGEMDOCK provides the visualizations of the protein-compound interaction profiles and the hierarchical clustering dendrogram of the compounds for post-screening analysis. Conclusions We have developed iGEMDOCK to facilitate steps from preparations of target proteins and ligand libraries toward post-screening analysis. iGEMDOCK is especially useful for post-screening analysis and inferring pharmacological interactions from screening compounds. We believe that iGEMDOCK is useful for understanding the ligand binding mechanisms and discovering lead compounds. iGEMDOCK is available at http://gemdock.life.nctu.edu.tw/dock/igemdock.php. BACKGROUND: Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred from a set of active compounds that were acquired experimentally. Moreover, most docking programs loosely coupled the stages (binding-site and ligand preparations, virtual screening, and post-screening analysis) of structure-based virtual screening (VS). An integrated VS environment, which provides the friendly interface to seamlessly combine these VS stages and to identify the pharmacological interactions directly from screening compounds, is valuable for drug discovery. RESULTS: We developed an easy-to-use graphic environment, iGEMDOCK, integrating VS stages (from preparations to post-screening analysis). For post-screening analysis, iGEMDOCK provides biological insights by deriving the pharmacological interactions from screening compounds without relying on the experimental data of active compounds. The pharmacological interactions represent conserved interacting residues, which often form binding pockets with specific physico-chemical properties, to play the essential functions of a target protein. Our experimental results show that the pharmacological interactions derived by iGEMDOCK are often hot spots involving in the biological functions. In addition, iGEMDOCK provides the visualizations of the protein-compound interaction profiles and the hierarchical clustering dendrogram of the compounds for post-screening analysis. CONCLUSIONS: We have developed iGEMDOCK to facilitate steps from preparations of target proteins and ligand libraries toward post-screening analysis. iGEMDOCK is especially useful for post-screening analysis and inferring pharmacological interactions from screening compounds. We believe that iGEMDOCK is useful for understanding the ligand binding mechanisms and discovering lead compounds. iGEMDOCK is available at http://gemdock.life.nctu.edu.tw/dock/igemdock.php. Abstract Background: Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred from a set of active compounds that were acquired experimentally. Moreover, most docking programs loosely coupled the stages (binding-site and ligand preparations, virtual screening, and post-screening analysis) of structure-based virtual screening (VS). An integrated VS environment, which provides the friendly interface to seamlessly combine these VS stages and to identify the pharmacological interactions directly from screening compounds, is valuable for drug discovery. Results: We developed an easy-to-use graphic environment, i GEMDOCK, integrating VS stages (from preparations to post-screening analysis). For post-screening analysis, i GEMDOCK provides biological insights by deriving the pharmacological interactions from screening compounds without relying on the experimental data of active compounds. The pharmacological interactions represent conserved interacting residues, which often form binding pockets with specific physico-chemical properties, to play the essential functions of a target protein. Our experimental results show that the pharmacological interactions derived by i GEMDOCK are often hot spots involving in the biological functions. In addition, i GEMDOCK provides the visualizations of the protein-compound interaction profiles and the hierarchical clustering dendrogram of the compounds for post-screening analysis. Conclusions: We have developed i GEMDOCK to facilitate steps from preparations of target proteins and ligand libraries toward post-screening analysis. i GEMDOCK is especially useful for post-screening analysis and inferring pharmacological interactions from screening compounds. We believe that i GEMDOCK is useful for understanding the ligand binding mechanisms and discovering lead compounds. i GEMDOCK is available at http://gemdock.life.nctu.edu.tw/dock/igemdock.php . Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred from a set of active compounds that were acquired experimentally. Moreover, most docking programs loosely coupled the stages (binding-site and ligand preparations, virtual screening, and post-screening analysis) of structure-based virtual screening (VS). An integrated VS environment, which provides the friendly interface to seamlessly combine these VS stages and to identify the pharmacological interactions directly from screening compounds, is valuable for drug discovery. We developed an easy-to-use graphic environment, iGEMDOCK, integrating VS stages (from preparations to post-screening analysis). For post-screening analysis, iGEMDOCK provides biological insights by deriving the pharmacological interactions from screening compounds without relying on the experimental data of active compounds. The pharmacological interactions represent conserved interacting residues, which often form binding pockets with specific physico-chemical properties, to play the essential functions of a target protein. Our experimental results show that the pharmacological interactions derived by iGEMDOCK are often hot spots involving in the biological functions. In addition, iGEMDOCK provides the visualizations of the protein-compound interaction profiles and the hierarchical clustering dendrogram of the compounds for post-screening analysis. We have developed iGEMDOCK to facilitate steps from preparations of target proteins and ligand libraries toward post-screening analysis. iGEMDOCK is especially useful for post-screening analysis and inferring pharmacological interactions from screening compounds. We believe that iGEMDOCK is useful for understanding the ligand binding mechanisms and discovering lead compounds. iGEMDOCK is available at http://gemdock.life.nctu.edu.tw/dock/igemdock.php. |
| ArticleNumber | S33 |
| Author | Hsu, Kai-Cheng Chen, Yen-Fu Yang, Jinn-Moon Lin, Shen-Rong |
| AuthorAffiliation | 1 Institute of Bioinformatics and Systems Biology, National Chiao Tung University, Hsinchu, 30050, Taiwan 2 Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, 30050, Taiwan 3 Core Facility for Structural Bioinformatics, National Chiao Tung University, Hsinchu, 30050, Taiwan |
| AuthorAffiliation_xml | – name: 3 Core Facility for Structural Bioinformatics, National Chiao Tung University, Hsinchu, 30050, Taiwan – name: 2 Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, 30050, Taiwan – name: 1 Institute of Bioinformatics and Systems Biology, National Chiao Tung University, Hsinchu, 30050, Taiwan |
| Author_xml | – sequence: 1 givenname: Kai-Cheng surname: Hsu fullname: Hsu, Kai-Cheng organization: Institute of Bioinformatics and Systems Biology, National Chiao Tung University, Hsinchu 30050, Taiwan – sequence: 2 givenname: Yen-Fu surname: Chen fullname: Chen, Yen-Fu – sequence: 3 givenname: Shen-Rong surname: Lin fullname: Lin, Shen-Rong – sequence: 4 givenname: Jinn-Moon surname: Yang fullname: Yang, Jinn-Moon |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21342564$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kk1v1DAQhiNURD_gFyChiAunFE9sJzEHJLS0paKoh8LZmjiTXa8Se7GTSv33JN3tqovUkz0z7zyar9PkyHlHSfIe2DlAVXwGUUKWA5MZ5FmELHL-KjnZe4-e_Y-T0xjXjEFZMfkmOc6Bi1wW4iQZ7dXFr--3i59fUkyXATcra7BLyd3b4F1Pbkh9O5krdMa6ZbpTp2Ocrc0KQ4_Gd375mGbdQAHNYL2LKbom3fg4ZNEEIjfr0WH3EG18m7xusYv0bveeJX8uL34vfmQ3t1fXi283WV2yashIklKyKduKuOG8xbwBkIwYGqrbppHY1KJVNZERUrU1FkrxUpZEshKVlPwsud5yG49rvQm2x_CgPVr96PBhqTEM1nSkG8YZVUIVDBoBtUIJRUkGSLVEhDSxvm5Zm7HuqTHTaAJ2B9DDiLMrvfT3mjMh8kpNgMstoLb-BcBhxPhezyvU8wo15PoO9B3nE-jTrpLg_44UB93baKjr0JEfo1ZSFFwAn_v_-J9y7ccwLWESMVCs5PmM41uRCT7GQO2-JGB6vrQXivjwfBz7nKfT4v8AfprT8A |
| CitedBy_id | crossref_primary_10_1016_j_molliq_2022_119650 crossref_primary_10_1016_j_ejmech_2022_114642 crossref_primary_10_1016_j_compbiolchem_2021_107513 crossref_primary_10_32604_biocell_2021_013277 crossref_primary_10_1016_j_jksus_2024_103134 crossref_primary_10_1016_j_molstruc_2021_131965 crossref_primary_10_58920_sciphy02010098 crossref_primary_10_1016_j_commatsci_2018_03_042 crossref_primary_10_13005_bbra_2590 crossref_primary_10_1096_fj_202000659R crossref_primary_10_2174_1573406419666230103142021 crossref_primary_10_3390_molecules27134200 crossref_primary_10_1080_10242422_2021_1955865 crossref_primary_10_1002_cbdv_202200399 crossref_primary_10_1039_D3NJ05774G crossref_primary_10_1109_TCBB_2019_2892099 crossref_primary_10_1007_s12247_021_09587_w crossref_primary_10_2174_1871520623666230607125258 crossref_primary_10_3390_plants12071495 crossref_primary_10_1016_j_molliq_2020_114872 crossref_primary_10_1080_07391102_2018_1556737 crossref_primary_10_1021_acs_jnatprod_6b00217 crossref_primary_10_1021_acsnano_0c07383 crossref_primary_10_3390_cancers14194719 crossref_primary_10_1016_j_bmcl_2012_05_008 crossref_primary_10_1007_s00894_023_05813_z crossref_primary_10_3390_md15120373 crossref_primary_10_1016_j_saa_2021_120677 crossref_primary_10_1111_mve_12662 crossref_primary_10_1007_s13738_024_02999_8 crossref_primary_10_1016_j_arabjc_2020_09_051 crossref_primary_10_2174_1871520623666221027094856 crossref_primary_10_1007_s00894_022_05131_w crossref_primary_10_1016_j_jtumed_2022_10_014 crossref_primary_10_1155_2021_6674261 crossref_primary_10_1016_j_ejmech_2023_115230 crossref_primary_10_17475_kastorman_1215281 crossref_primary_10_1016_j_jmgm_2019_02_005 crossref_primary_10_1080_07391102_2020_1752310 crossref_primary_10_52711_0974_360X_2022_00250 crossref_primary_10_1002_jhet_4858 crossref_primary_10_1002_ps_7700 crossref_primary_10_1016_j_molstruc_2024_138522 crossref_primary_10_1128_JB_01945_14 crossref_primary_10_1007_s11224_022_01887_2 crossref_primary_10_3390_biomedicines11112914 crossref_primary_10_1186_s12918_017_0506_1 crossref_primary_10_17656_jsmc_10276 crossref_primary_10_1016_j_biopha_2023_114481 crossref_primary_10_1007_s11010_016_2777_z crossref_primary_10_1016_j_jics_2021_100328 crossref_primary_10_4028_www_scientific_net_KEM_901_3 crossref_primary_10_1016_j_molliq_2023_123530 crossref_primary_10_1371_journal_pone_0289890 crossref_primary_10_3390_molecules27051513 crossref_primary_10_1016_j_ijantimicag_2023_106774 crossref_primary_10_1016_j_arabjc_2020_05_035 crossref_primary_10_1016_j_arabjc_2022_103882 crossref_primary_10_1007_s11033_023_09177_8 crossref_primary_10_1038_s41467_019_10920_8 crossref_primary_10_3390_antiox8120646 crossref_primary_10_1111_bcpt_12057 crossref_primary_10_1016_j_bcp_2021_114429 crossref_primary_10_1002_iub_2167 crossref_primary_10_1016_j_micpath_2020_104563 crossref_primary_10_1093_bib_bbv037 crossref_primary_10_1016_j_toxicon_2018_11_308 crossref_primary_10_1371_journal_pone_0056704 crossref_primary_10_3390_molecules28165936 crossref_primary_10_4155_fmc_2021_0020 crossref_primary_10_3390_antibiotics10111401 crossref_primary_10_1016_j_bioorg_2020_104460 crossref_primary_10_2174_1573408018666220802113450 crossref_primary_10_15406_jcpcr_2017_08_00268 crossref_primary_10_1016_j_poly_2024_116980 crossref_primary_10_1016_j_molstruc_2018_08_049 crossref_primary_10_1021_jm500249n crossref_primary_10_1098_rsos_181321 crossref_primary_10_33435_tcandtc_1003157 crossref_primary_10_1007_s00894_023_05479_7 crossref_primary_10_1016_j_molstruc_2021_131924 crossref_primary_10_1002_aoc_4725 crossref_primary_10_4155_fmc_2019_0016 crossref_primary_10_3389_fpls_2023_1220339 crossref_primary_10_1021_acs_jmedchem_9b01783 crossref_primary_10_22159_ajpcr_2021_v14i7_40792 crossref_primary_10_1016_j_enzmictec_2018_06_005 crossref_primary_10_1155_2013_682418 crossref_primary_10_1186_s12906_023_04269_1 crossref_primary_10_3390_cancers12051324 crossref_primary_10_1021_acs_molpharmaceut_9b01071 crossref_primary_10_1073_pnas_1517288113 crossref_primary_10_3390_cells11121924 crossref_primary_10_1016_j_heliyon_2022_e09034 crossref_primary_10_3390_ph16020280 crossref_primary_10_1038_s41598_023_48411_y crossref_primary_10_1007_s00044_022_02876_0 crossref_primary_10_3389_fphar_2021_720018 crossref_primary_10_1038_s41598_020_67420_9 crossref_primary_10_1371_journal_pone_0057140 crossref_primary_10_1007_s11626_022_00666_x crossref_primary_10_1007_s13738_016_0869_z crossref_primary_10_3390_molecules28196950 crossref_primary_10_1007_s10895_024_03687_9 crossref_primary_10_3389_fphar_2018_01379 crossref_primary_10_1093_jpp_rgab166 crossref_primary_10_1016_j_chemolab_2021_104394 crossref_primary_10_1016_j_molstruc_2016_10_079 crossref_primary_10_1007_s42250_023_00611_9 crossref_primary_10_3389_fchem_2020_00343 crossref_primary_10_1016_j_bcp_2013_04_011 crossref_primary_10_1016_j_molstruc_2017_01_074 crossref_primary_10_1038_s41598_023_40669_6 crossref_primary_10_37394_232023_2024_4_1 crossref_primary_10_1007_s13205_016_0422_x crossref_primary_10_1080_07391102_2016_1197152 crossref_primary_10_1039_D3RA03087C crossref_primary_10_52711_0974_360X_2022_00743 crossref_primary_10_1080_07391102_2021_1970024 crossref_primary_10_1016_j_phytochem_2024_114015 crossref_primary_10_1186_s13578_023_01154_9 crossref_primary_10_1016_j_jep_2022_115800 crossref_primary_10_1016_j_bioorg_2021_104831 crossref_primary_10_1002_minf_201800007 crossref_primary_10_1080_07391102_2020_1841030 crossref_primary_10_1016_j_jphotobiol_2016_08_045 crossref_primary_10_1155_2021_4490081 crossref_primary_10_1371_journal_pone_0055793 crossref_primary_10_1016_j_jksus_2022_102157 crossref_primary_10_1016_j_matpr_2021_02_377 crossref_primary_10_18632_oncotarget_27558 crossref_primary_10_1016_j_rechem_2023_101096 crossref_primary_10_1080_07391102_2021_1930161 crossref_primary_10_3390_molecules23081897 crossref_primary_10_3390_pharmaceutics15102411 crossref_primary_10_1080_07391102_2022_2087103 crossref_primary_10_1007_s10973_013_3319_5 crossref_primary_10_22207_JPAM_14_SPL1_37 crossref_primary_10_1080_07391102_2020_1851299 crossref_primary_10_1002_jcc_27390 crossref_primary_10_1007_s12013_016_0735_8 crossref_primary_10_1038_s41598_024_63735_z crossref_primary_10_1016_j_molstruc_2020_129517 crossref_primary_10_1007_s43994_023_00114_w crossref_primary_10_1177_1934578X20953951 crossref_primary_10_7314_APJCP_2016_17_4_2311 crossref_primary_10_3390_ijerph16060923 crossref_primary_10_1002_jmr_2266 crossref_primary_10_1016_j_matpr_2021_02_383 crossref_primary_10_1016_j_jtice_2024_105535 crossref_primary_10_1080_07391102_2021_2014973 crossref_primary_10_1080_07391102_2019_1704882 crossref_primary_10_13005_bpj_2291 crossref_primary_10_1016_j_heliyon_2023_e21122 crossref_primary_10_1038_s41598_020_65489_w crossref_primary_10_3389_fchem_2022_912822 crossref_primary_10_1016_j_tet_2024_133907 crossref_primary_10_3892_or_2021_8217 crossref_primary_10_1080_07391102_2023_2274970 crossref_primary_10_53879_id_58_08_12930 crossref_primary_10_3390_scipharm88010002 crossref_primary_10_1002_jcb_29954 crossref_primary_10_1073_pnas_1801189115 crossref_primary_10_1093_jac_dkw194 crossref_primary_10_1080_17568919_2024_2342668 crossref_primary_10_1021_acsomega_3c05769 crossref_primary_10_1038_s41598_017_03417_1 crossref_primary_10_1080_07391102_2021_1987329 crossref_primary_10_2174_1570179417666201209141222 crossref_primary_10_2174_1573406418666220427105041 crossref_primary_10_4103_pm_pm_518_21 crossref_primary_10_1080_07391102_2020_1847194 crossref_primary_10_1016_j_molstruc_2017_08_092 crossref_primary_10_1021_np400083k crossref_primary_10_1016_j_heliyon_2021_e06515 crossref_primary_10_33084_jmd_v2i1_3450 crossref_primary_10_1016_j_adcanc_2022_100030 crossref_primary_10_14233_ajomc_2019_AJOMC_P237 crossref_primary_10_22159_ijpps_2022v14i8_44560 crossref_primary_10_1016_j_molstruc_2019_02_106 crossref_primary_10_1002_biof_1193 crossref_primary_10_1016_j_imu_2021_100833 crossref_primary_10_1002_jccs_202000019 crossref_primary_10_1093_jme_tjac043 crossref_primary_10_2217_fvl_2020_0403 crossref_primary_10_1007_s10822_013_9665_3 crossref_primary_10_3390_ijms24119335 crossref_primary_10_3390_jpm11080782 crossref_primary_10_1016_j_molliq_2022_120935 crossref_primary_10_1002_jcc_27298 crossref_primary_10_1039_D2FO00357K crossref_primary_10_2174_1389557519666190222172757 crossref_primary_10_3390_ph14121337 crossref_primary_10_18632_oncotarget_15115 crossref_primary_10_1080_07391102_2021_1904004 crossref_primary_10_1186_s12864_017_3503_2 crossref_primary_10_1186_s43042_024_00486_6 crossref_primary_10_1016_j_ica_2021_120748 crossref_primary_10_1016_j_chemphys_2024_112243 crossref_primary_10_2144_fsoa_2022_0085 crossref_primary_10_1016_j_molstruc_2017_12_045 crossref_primary_10_1021_ci400227r crossref_primary_10_1016_j_cdc_2020_100593 crossref_primary_10_1155_2018_7692913 crossref_primary_10_1016_j_sajb_2020_11_021 crossref_primary_10_1038_s41598_023_46181_1 crossref_primary_10_1016_j_matpr_2020_11_844 crossref_primary_10_1186_s13065_023_00962_x crossref_primary_10_3390_bioengineering10121361 crossref_primary_10_1002_jcb_28049 crossref_primary_10_1016_j_ejphar_2020_173195 crossref_primary_10_1038_s41598_017_12101_3 crossref_primary_10_1007_s11030_023_10646_2 crossref_primary_10_1016_j_heliyon_2024_e27880 crossref_primary_10_1007_s43994_023_00093_y crossref_primary_10_1016_j_sajb_2022_11_038 crossref_primary_10_1007_s11030_022_10377_w crossref_primary_10_1016_j_talanta_2013_05_061 crossref_primary_10_1016_j_kjs_2024_100230 crossref_primary_10_53447_communc_934706 crossref_primary_10_1080_02286203_2021_1923953 crossref_primary_10_1002_cbdv_202100361 crossref_primary_10_1016_j_neuro_2015_03_009 crossref_primary_10_1134_S1068162018050072 crossref_primary_10_1016_j_heliyon_2023_e17777 crossref_primary_10_1080_07391102_2020_1832918 crossref_primary_10_1080_1062936X_2017_1385532 crossref_primary_10_1080_07391102_2022_2029770 crossref_primary_10_1016_j_theriogenology_2017_09_017 crossref_primary_10_1007_s13205_023_03912_5 crossref_primary_10_1016_j_molstruc_2019_06_038 crossref_primary_10_3389_fmicb_2020_01796 crossref_primary_10_3390_ph13070154 crossref_primary_10_1016_j_dcmed_2020_09_003 crossref_primary_10_1002_slct_201902609 crossref_primary_10_52711_0974_360X_2023_00937 crossref_primary_10_1016_j_molstruc_2018_07_110 crossref_primary_10_1186_s12859_017_1957_5 crossref_primary_10_3389_fmicb_2016_00452 crossref_primary_10_3390_molecules26061653 crossref_primary_10_4103_njecp_njecp_15_22 crossref_primary_10_1007_s00044_013_0882_z crossref_primary_10_1016_j_abb_2024_109889 crossref_primary_10_1186_s13020_020_00401_2 crossref_primary_10_3389_fphar_2024_1310009 crossref_primary_10_1016_j_jscs_2021_101285 crossref_primary_10_1016_j_imu_2022_101063 crossref_primary_10_1007_s10930_015_9611_4 crossref_primary_10_1038_srep10938 crossref_primary_10_1155_2022_2198722 crossref_primary_10_1016_j_compbiolchem_2020_107268 crossref_primary_10_1016_j_virol_2023_06_011 crossref_primary_10_1080_07391102_2021_1873863 crossref_primary_10_1158_1078_0432_CCR_17_2066 crossref_primary_10_2174_1389557519666191015130037 crossref_primary_10_1016_j_molstruc_2020_129451 crossref_primary_10_1039_C4MB00307A crossref_primary_10_1007_s13205_023_03626_8 crossref_primary_10_1007_s12012_021_09655_0 crossref_primary_10_2147_DDDT_S447289 crossref_primary_10_1080_10406638_2022_2112704 crossref_primary_10_1007_s40200_023_01191_8 crossref_primary_10_1016_j_antiviral_2016_11_005 crossref_primary_10_1080_07391102_2023_2245483 crossref_primary_10_2174_1573408018666220516104525 crossref_primary_10_1016_j_imu_2023_101170 crossref_primary_10_1002_slct_201701484 crossref_primary_10_1016_j_ejmech_2019_02_057 crossref_primary_10_1007_s00044_016_1686_8 crossref_primary_10_2174_2666796701999201113114545 crossref_primary_10_1007_s10822_011_9465_6 crossref_primary_10_1016_j_compbiolchem_2017_09_002 crossref_primary_10_1080_07391102_2023_2232041 crossref_primary_10_1080_1062936X_2022_2050424 crossref_primary_10_1002_pro_5007 crossref_primary_10_1016_j_biopha_2021_112459 crossref_primary_10_2174_1573409915666191025112150 crossref_primary_10_1155_2021_6687589 crossref_primary_10_1007_s12195_020_00658_5 crossref_primary_10_1002_appl_202100010 crossref_primary_10_1016_j_bmc_2013_06_054 crossref_primary_10_3390_molecules28020540 crossref_primary_10_1016_j_ejmech_2017_11_092 crossref_primary_10_1002_poc_4287 crossref_primary_10_1016_j_biopha_2021_112580 crossref_primary_10_2174_1386207325666220421104008 crossref_primary_10_1155_2015_506564 crossref_primary_10_2174_1871520622666220204123348 crossref_primary_10_1371_journal_pone_0033481 crossref_primary_10_1134_S1068162021050204 crossref_primary_10_1016_j_cplett_2021_138894 crossref_primary_10_1021_acs_jmedchem_6b00794 crossref_primary_10_3390_nu15020453 crossref_primary_10_2174_1573409915666190528114703 crossref_primary_10_1080_17518253_2021_1981462 crossref_primary_10_2174_1568026620666201207095626 crossref_primary_10_1016_j_tetlet_2013_09_087 crossref_primary_10_1080_07391102_2017_1334596 crossref_primary_10_1021_acsomega_1c03978 crossref_primary_10_1016_j_intimp_2014_04_013 crossref_primary_10_1007_s11030_024_10831_x crossref_primary_10_1016_j_jtumed_2022_09_011 crossref_primary_10_18632_oncotarget_10960 crossref_primary_10_1016_j_envpol_2024_123949 crossref_primary_10_1080_07391102_2023_2258404 crossref_primary_10_1007_s11164_022_04933_0 crossref_primary_10_3390_molecules27196590 crossref_primary_10_1089_adt_2023_060 crossref_primary_10_1007_s10904_019_01090_7 crossref_primary_10_3389_fimmu_2022_872047 crossref_primary_10_1016_j_jics_2022_100433 crossref_primary_10_2174_1566523220999200726225457 crossref_primary_10_1111_tmi_13635 crossref_primary_10_1039_C4FO00302K crossref_primary_10_1007_s00726_021_03098_1 crossref_primary_10_1016_j_ijbiomac_2023_125791 crossref_primary_10_1016_j_jics_2022_100790 crossref_primary_10_2174_1871526520666200727153643 |
| Cites_doi | 10.1021/bi992453q 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8 10.1016/S0092-8674(00)81717-1 10.1002/prot.20387 10.1002/1097-0134(20000901)40:4<623::AID-PROT70>3.0.CO;2-I 10.1016/j.jmb.2009.11.076 10.1021/ci020055f 10.1021/jm049059x 10.1093/bioinformatics/bth349 10.1016/j.str.2004.09.015 10.1002/prot.10232 10.1074/jbc.274.45.31967 10.1074/jbc.M200764200 10.1021/jm001044l 10.1021/cg800697s 10.1074/jbc.M010223200 10.1002/(SICI)1097-0134(19980815)32:3<350::AID-PROT10>3.0.CO;2-8 10.1038/nrd2615 10.1046/j.1432-1327.1998.2550472.x 10.1002/prot.20035 10.1016/S0968-0004(00)89080-5 10.1016/S1359-6446(02)02483-2 10.1016/j.antiviral.2008.10.006 10.1007/BF00124499 10.1021/jm070079j 10.1021/jm061035y 10.1006/jmbi.1996.0897 10.1099/0022-1317-79-9-2083 10.1371/journal.pone.0000428 10.1007/s10822-008-9250-3 10.1038/nrd1549 10.1038/39645 10.1021/jm051112+ 10.1016/j.drudis.2007.09.007 10.1002/pro.5560061005 |
| ContentType | Journal Article |
| Copyright | 2011 Hsu et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2011 Hsu et al; licensee BioMed Central Ltd. 2011 Hsu et al; licensee BioMed Central Ltd. |
| Copyright_xml | – notice: 2011 Hsu et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2011 Hsu et al; licensee BioMed Central Ltd. 2011 Hsu et al; licensee BioMed Central Ltd. |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QO 7SC 7X7 7XB 88E 8AL 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ JQ2 K7- K9. L7M LK8 L~C L~D M0N M0S M1P M7P P5Z P62 P64 PIMPY PQEST PQQKQ PQUKI Q9U 5PM DOA |
| DOI | 10.1186/1471-2105-12-s1-s33 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Biotechnology Research Abstracts Computer and Information Systems Abstracts ProQuest_Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Computing Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central Technology Collection ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Computer Science Collection Computer Science Database ProQuest Health & Medical Complete (Alumni) Advanced Technologies Database with Aerospace Biological Sciences Computer and Information Systems Abstracts Academic Computer and Information Systems Abstracts Professional Computing Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Publicly Available Content Database (Proquest) (PQ_SDU_P3) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database Computer Science Database ProQuest Central Student Technology Collection Technology Research Database Computer and Information Systems Abstracts – Academic ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Computer Science Collection ProQuest Health & Medical Complete (Alumni) Computer and Information Systems Abstracts ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection Advanced Technologies Database with Aerospace ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Computing ProQuest Biological Science Collection ProQuest Central Basic ProQuest Computing (Alumni Edition) ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Computer and Information Systems Abstracts Professional Advanced Technologies & Aerospace Database ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) |
| DatabaseTitleList | Engineering Research Database Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1471-2105 |
| EndPage | S33 |
| ExternalDocumentID | oai_doaj_org_article_d030e849601d41b9a5167ec1e9feeeae oai_biomedcentral_com_1471_2105_12_S1_S33 2501807881 10_1186_1471_2105_12_S1_S33 21342564 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -A0 0R~ 23N 2VQ 2WC 3V. 4.4 53G 5VS 6J9 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAFWJ AAJSJ AAKPC ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFRAH AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS ARAPS AZQEC BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BGLVJ BHPHI BMC BPHCQ BVXVI C1A C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 DWQXO E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EJD EMB EMK EMOBN ESX F5P FYUFA GNUQQ GROUPED_DOAJ GX1 H13 HCIFZ HMCUK HYE IAO IHR INH INR IPNFZ ISR ITC K6V K7- KQ8 LK8 M0N M1P M48 M7P MK~ ML0 M~E NPM O5R O5S OK1 P2P P62 PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RIG RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XH6 XSB AAYXX CITATION 7QO 7SC 7XB 8AL 8FD 8FK FR3 JQ2 K9. L7M L~C L~D P64 PQEST PQUKI Q9U ABVAZ AFGXO AFNRJ AFPKN 5PM |
| ID | FETCH-LOGICAL-b708t-e5e995d7f8e3c33fa2d1150e0acebfdd5adb4f9beec459fba6993757ee5848553 |
| IEDL.DBID | RPM |
| ISSN | 1471-2105 |
| IngestDate | Tue Oct 22 15:14:00 EDT 2024 Tue Sep 17 21:25:02 EDT 2024 Wed May 22 07:17:19 EDT 2024 Fri Oct 25 08:38:41 EDT 2024 Thu Oct 10 20:30:52 EDT 2024 Fri Nov 22 00:55:30 EST 2024 Tue Oct 15 23:38:59 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | S1 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b708t-e5e995d7f8e3c33fa2d1150e0acebfdd5adb4f9beec459fba6993757ee5848553 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044289/ |
| PMID | 21342564 |
| PQID | 901907323 |
| PQPubID | 44065 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_d030e849601d41b9a5167ec1e9feeeae pubmedcentral_primary_oai_pubmedcentral_nih_gov_3044289 biomedcentral_primary_oai_biomedcentral_com_1471_2105_12_S1_S33 proquest_miscellaneous_954634135 proquest_journals_901907323 crossref_primary_10_1186_1471_2105_12_S1_S33 pubmed_primary_21342564 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-02-15 |
| PublicationDateYYYYMMDD | 2011-02-15 |
| PublicationDate_xml | – month: 02 year: 2011 text: 2011-02-15 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | BMC bioinformatics |
| PublicationTitleAlternate | BMC Bioinformatics |
| PublicationYear | 2011 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | 17502914 - PLoS One. 2007;2(5):e428 19014974 - Antiviral Res. 2009 Feb;81(2):123-31 9336833 - Protein Sci. 1997 Oct;6(10):2097-106 17489582 - J Med Chem. 2007 May 31;50(11):2682-92 12402356 - Proteins. 2002 Dec 1;49(4):457-71 9875847 - Cell. 1998 Dec 23;95(7):927-37 10584068 - Proteins. 1999 Nov 1;37(2):228-41 12546562 - J Chem Inf Comput Sci. 2003 Jan-Feb;43(1):267-72 20004667 - J Mol Biol. 2010 Feb 26;396(3):646-62 9715911 - Proteins. 1998 Aug 15;32(3):350-61 10899786 - Proteins. 2000 Sep 1;40(4):623-36 18190860 - Drug Discov Today. 2008 Jan;13(1-2):23-9 9338790 - Nature. 1997 Oct 16;389(6652):753-8 18989626 - J Comput Aided Mol Des. 2009 Mar;23(3):185-94 15726586 - Proteins. 2005 May 1;59(2):205-20 11937504 - J Biol Chem. 2002 Jun 14;277(24):21862-8 15576033 - Structure. 2004 Dec;12(12):2197-207 11262392 - J Biol Chem. 2001 Jun 15;276(24):21692-7 9716390 - Eur J Biochem. 1998 Jul 15;255(2):472-81 15520816 - Nat Rev Drug Discov. 2004 Nov;3(11):935-49 10542226 - J Biol Chem. 1999 Nov 5;274(45):31967-73 15048822 - Proteins. 2004 May 1;55(2):288-304 11123984 - J Med Chem. 2000 Dec 14;43(25):4759-67 10747801 - Biochemistry. 2000 Apr 11;39(14):4105-11 17228884 - J Med Chem. 2007 Jan 25;50(2):399-403 9747715 - J Gen Virol. 1998 Sep;79 ( Pt 9):2083-92 8877701 - J Comput Aided Mol Des. 1996 Aug;10(4):293-304 16821770 - J Med Chem. 2006 Jul 13;49(14):4085-97 9126849 - J Mol Biol. 1997 Apr 4;267(3):727-48 15180930 - Bioinformatics. 2004 Nov 22;20(17):3246-8 15916444 - J Med Chem. 2005 Jun 2;48(11):3919-29 12546894 - Drug Discov Today. 2002 Oct 15;7(20):1047-55 18636071 - Nat Rev Drug Discov. 2008 Aug;7(8):667-77 7482707 - Trends Biochem Sci. 1995 Sep;20(9):374 H Shadnia (4391_CR29) 2009; 23 G Wolber (4391_CR10) 2008; 13 PD Lyne (4391_CR1) 2002; 7 HC Hung (4391_CR13) 2009; 81 JN Champness (4391_CR17) 1998; 32 A Tafi (4391_CR9) 2006; 49 JM Yang (4391_CR11) 2007; 2 S Kussmann-Gerber (4391_CR31) 1998; 255 K Wild (4391_CR30) 1997; 6 Y Pan (4391_CR35) 2003; 43 ES Manas (4391_CR27) 2004; 12 GM Morris (4391_CR6) 1996; 10 JM Yang (4391_CR8) 2005; 59 AK Shiau (4391_CR16) 1998; 95 J-M Yang (4391_CR24) 2005; 59 AJ Saldanha (4391_CR23) 2004; 20 B Kramer (4391_CR5) 1999; 37 KH Chin (4391_CR12) 2010; 396 Y Tanrikulu (4391_CR2) 2008; 7 JW Nissink (4391_CR20) 2002; 49 G Jones (4391_CR7) 1997; 267 A Warnmark (4391_CR15) 2002; 277 M-C Yang (4391_CR14) 2008; 8 JS Evans (4391_CR34) 1998; 79 BD Pilger (4391_CR33) 1999; 274 AM Brzozowski (4391_CR28) 1997; 389 RA Sayle (4391_CR22) 1995; 20 M Sulpizi (4391_CR36) 2001; 276 TA Hinds (4391_CR32) 2000; 39 DB Kitchen (4391_CR3) 2004; 3 Z Qin (4391_CR26) 2007; 50 X Fradera (4391_CR25) 2000; 40 A Manikowski (4391_CR19) 2005; 48 J-M Yang (4391_CR4) 2004; 55 C Bissantz (4391_CR21) 2000; 43 HB Zhou (4391_CR18) 2007; 50 |
| References_xml | – volume: 39 start-page: 4105 year: 2000 ident: 4391_CR32 publication-title: Biochemistry doi: 10.1021/bi992453q contributor: fullname: TA Hinds – volume: 37 start-page: 228 year: 1999 ident: 4391_CR5 publication-title: Proteins doi: 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8 contributor: fullname: B Kramer – volume: 95 start-page: 927 year: 1998 ident: 4391_CR16 publication-title: Cell doi: 10.1016/S0092-8674(00)81717-1 contributor: fullname: AK Shiau – volume: 59 start-page: 205 year: 2005 ident: 4391_CR24 publication-title: Proteins doi: 10.1002/prot.20387 contributor: fullname: J-M Yang – volume: 40 start-page: 623 year: 2000 ident: 4391_CR25 publication-title: Proteins doi: 10.1002/1097-0134(20000901)40:4<623::AID-PROT70>3.0.CO;2-I contributor: fullname: X Fradera – volume: 396 start-page: 646 year: 2010 ident: 4391_CR12 publication-title: Journal of Molecular Biology doi: 10.1016/j.jmb.2009.11.076 contributor: fullname: KH Chin – volume: 43 start-page: 267 issue: 1 year: 2003 ident: 4391_CR35 publication-title: J Chem Inf Comput Sci doi: 10.1021/ci020055f contributor: fullname: Y Pan – volume: 48 start-page: 3919 year: 2005 ident: 4391_CR19 publication-title: Journal of Medicinal Chemistry doi: 10.1021/jm049059x contributor: fullname: A Manikowski – volume: 20 start-page: 3246 year: 2004 ident: 4391_CR23 publication-title: Bioinformatics doi: 10.1093/bioinformatics/bth349 contributor: fullname: AJ Saldanha – volume: 12 start-page: 2197 year: 2004 ident: 4391_CR27 publication-title: Structure doi: 10.1016/j.str.2004.09.015 contributor: fullname: ES Manas – volume: 49 start-page: 457 year: 2002 ident: 4391_CR20 publication-title: Proteins doi: 10.1002/prot.10232 contributor: fullname: JW Nissink – volume: 274 start-page: 31967 year: 1999 ident: 4391_CR33 publication-title: The Journal of Biological Chemistry doi: 10.1074/jbc.274.45.31967 contributor: fullname: BD Pilger – volume: 277 start-page: 21862 year: 2002 ident: 4391_CR15 publication-title: Journal of Biological Chemistry doi: 10.1074/jbc.M200764200 contributor: fullname: A Warnmark – volume: 43 start-page: 4759 year: 2000 ident: 4391_CR21 publication-title: Journal of Medicinal Chemistry doi: 10.1021/jm001044l contributor: fullname: C Bissantz – volume: 8 start-page: 4268 year: 2008 ident: 4391_CR14 publication-title: Crystal Growth & Design doi: 10.1021/cg800697s contributor: fullname: M-C Yang – volume: 276 start-page: 21692 year: 2001 ident: 4391_CR36 publication-title: The Journal of Biological Chemistry doi: 10.1074/jbc.M010223200 contributor: fullname: M Sulpizi – volume: 32 start-page: 350 year: 1998 ident: 4391_CR17 publication-title: Proteins doi: 10.1002/(SICI)1097-0134(19980815)32:3<350::AID-PROT10>3.0.CO;2-8 contributor: fullname: JN Champness – volume: 7 start-page: 667 year: 2008 ident: 4391_CR2 publication-title: Nature Reviews Drug Discovery doi: 10.1038/nrd2615 contributor: fullname: Y Tanrikulu – volume: 255 start-page: 472 year: 1998 ident: 4391_CR31 publication-title: European Journal of Biochemistry / FEBS doi: 10.1046/j.1432-1327.1998.2550472.x contributor: fullname: S Kussmann-Gerber – volume: 55 start-page: 288 year: 2004 ident: 4391_CR4 publication-title: Proteins doi: 10.1002/prot.20035 contributor: fullname: J-M Yang – volume: 20 start-page: 374 year: 1995 ident: 4391_CR22 publication-title: Trends in Biochemical Sciences doi: 10.1016/S0968-0004(00)89080-5 contributor: fullname: RA Sayle – volume: 7 start-page: 1047 year: 2002 ident: 4391_CR1 publication-title: Drug Discovery Today doi: 10.1016/S1359-6446(02)02483-2 contributor: fullname: PD Lyne – volume: 81 start-page: 123 year: 2009 ident: 4391_CR13 publication-title: Antiviral Research doi: 10.1016/j.antiviral.2008.10.006 contributor: fullname: HC Hung – volume: 59 start-page: 205 issue: 2 year: 2005 ident: 4391_CR8 publication-title: Proteins doi: 10.1002/prot.20387 contributor: fullname: JM Yang – volume: 10 start-page: 293 year: 1996 ident: 4391_CR6 publication-title: Journal of Computer-Aided Molecular Design doi: 10.1007/BF00124499 contributor: fullname: GM Morris – volume: 50 start-page: 2682 year: 2007 ident: 4391_CR26 publication-title: Journal of Medicinal Chemistry doi: 10.1021/jm070079j contributor: fullname: Z Qin – volume: 50 start-page: 399 year: 2007 ident: 4391_CR18 publication-title: Journal of Medicinal Chemistry doi: 10.1021/jm061035y contributor: fullname: HB Zhou – volume: 267 start-page: 727 year: 1997 ident: 4391_CR7 publication-title: Journal of Molecular Biology doi: 10.1006/jmbi.1996.0897 contributor: fullname: G Jones – volume: 79 start-page: 2083 year: 1998 ident: 4391_CR34 publication-title: The Journal of General Virology doi: 10.1099/0022-1317-79-9-2083 contributor: fullname: JS Evans – volume: 2 start-page: e428 year: 2007 ident: 4391_CR11 publication-title: PLoS One doi: 10.1371/journal.pone.0000428 contributor: fullname: JM Yang – volume: 23 start-page: 185 year: 2009 ident: 4391_CR29 publication-title: Journal of Computer-aided Molecular Design doi: 10.1007/s10822-008-9250-3 contributor: fullname: H Shadnia – volume: 3 start-page: 935 year: 2004 ident: 4391_CR3 publication-title: Nature Reviews Drug Discovery doi: 10.1038/nrd1549 contributor: fullname: DB Kitchen – volume: 389 start-page: 753 year: 1997 ident: 4391_CR28 publication-title: Nature doi: 10.1038/39645 contributor: fullname: AM Brzozowski – volume: 49 start-page: 4085 year: 2006 ident: 4391_CR9 publication-title: Journal of Medicinal Chemistry doi: 10.1021/jm051112+ contributor: fullname: A Tafi – volume: 13 start-page: 23 year: 2008 ident: 4391_CR10 publication-title: Drug Discovery Today doi: 10.1016/j.drudis.2007.09.007 contributor: fullname: G Wolber – volume: 6 start-page: 2097 year: 1997 ident: 4391_CR30 publication-title: Protein Sci doi: 10.1002/pro.5560061005 contributor: fullname: K Wild |
| SSID | ssj0017805 |
| Score | 2.5628479 |
| Snippet | Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred from a set... Abstract Background: Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often... BACKGROUND: Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred... Abstract Background Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often... |
| SourceID | doaj pubmedcentral biomedcentral proquest crossref pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | S33 |
| SubjectTerms | Accuracy Binding Sites Computer Graphics Drug Discovery Information Storage and Retrieval Libraries Ligands Models, Molecular Molecular weight Protein Binding Proteins Proteins - chemistry Software |
| SummonAdditionalLinks | – databaseName: BioMed Central dbid: RBZ link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoERIXKK8SSpEPHLGIEzu2uSDabqmEAIkFCXGxnHjcVkLZVXf3wL9nJkmXptoeUI-J7diZl2dsz2fGXpsa52TjotDSNkIlVQlrpRaNy0GiwbSQaCn7ZGq-_LRHE4LJEZt38KWt3ko0nwIDE02HCKZSTMtyi93FqEGRQH87-LXeNCB4_i6ZaGgwgAzd8JFrGe6_RxNTh9-_yem8fnbyymR0_PA_f2OHPRi8Tv6hF5NH7A60j9m9_h7KP0_Y6vzj5PPR18NP73jgHYQ1sY5fSYLjs4SPZwTO0Z7yoTanQ_OnfP4P_bprRggUF32-xIKHNvL5bLEUaJ4wZKb6YcBBecp-HE--H56I4T4GUZvcLgVocE5HkyyUTVmmUETyJyEPDdQpRh1irZKrARqlXapDRc6PNgDo5Vity2dsu5218JzxGKqY6uTo-koFeeOKiJ5HHRpjTGlck7H3I-b4eY-94QkNe1yCiumJuJ6I62Xhp9IjcTP25pKd68ZdwGOrzdUPiOWjfroXyEM_KLGPaBHBKgz6ZFSydkHLykAjwSUACJCxvUuB8YMpWHhH2fqmLLALvi5FHaaNmdDCbIVV6E4C9CZ0xnZ76VqPgwD30CtVGTMjuRsNdFzSnp91MOFlrjC2dC9uTco9dr9fSS-E1C_Z9vJiBftsaxFXrzoF_AvNmCzp priority: 500 providerName: BioMedCentral – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagEhIXxJtQQD5wxGqcxLHNBUG7pRICDgsSN8uOx20llF11dw_8e2acbGhQJS4c44cce8b2N7bnG8Ze64B7srZRKGk60aSmFcZIJTpbgsQF00Cio-yzpf7yw5wsiCZnCvVFb8IGeuBh4I4iaiGYBoG2jI0M1ivZaugk2AQAHvLqW7Z7Y2q8PyCm_uxXpKXAbDXyDUnTHk1p9ChhKcWSYubOnN1_zvaoTOV_E_78-xnltX3p9D67NwJK_n7oyAN2C_qH7M4QYvLXI7a7_Lj4fPL1-NNb7nlmpyap8Gv-bXyV8POCeDf6cz6W5vQe_pyv_xBb52pELnE1uEJsuO8jX682W4ErD1rDVN6PFCeP2ffTxbfjMzGGWhBBl2YrQIG1KupkoO7qOvkqElSE0ncQUozKx9AkGwC6RtkUfEu4RmkABDBGqfoJO-hXPTxjPPo2ppAsRaZsoOxsFRFUBN9prWttu4K9mw22Ww-0Go6Iruc5OOccicuRuJys3FI6FFfB3uzFM1XOtoxpby7-gUQ4aycnoJq5Uc3cv9SsYId7BXDjLN84S474uq6wCT7l4vSkOxffw2qHRSjcAAIFVbCng7ZM_0Fcegg4m4LpmR7NfnSe019eZAbwumzQbLTP_0fPDtnd4Zy8ElK9YAfbqx28ZLc3cfcqz6nf8YgnXA priority: 102 providerName: Directory of Open Access Journals |
| Title | iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/21342564 https://www.proquest.com/docview/901907323 https://search.proquest.com/docview/954634135 http://dx.doi.org/10.1186/1471-2105-12-S1-S33 https://pubmed.ncbi.nlm.nih.gov/PMC3044289 https://doaj.org/article/d030e849601d41b9a5167ec1e9feeeae |
| Volume | 12 Suppl 1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbYSkhcEG9CofKBI-6uN3Fsc0F0u6USKiAWJMTFcuzxdqU2u9rHgX_P2EmWpuqJS6TEtmxlZuxv7JnPhLyVFa7JUnsmuHKsCEXJlOKCOT0CjhOmghC3ss9n8ssvdTqNNDmiy4VJQfuuWhzXV9fH9eIyxVaurt2wixMbfruYoAuOqFkPB2SA2LBz0dujg0jS39ILcVUOOc6-DP0aEWMQZpzN8jwRAOeorOXtNPer3uqUSPzvQp63AyhvrEhnj8jDFkrSj82QH5N7UD8h95vLJf88JbvFp-nF6dfJ5_fU0sRLHeVBb2S20WXA18vIuFHPaVubxkj4OV39o7ROzSKtxLpJgthQW3u6Wm62DOcc9INjfduSmzwjP8-mPybnrL1kgVVypLYMBGgtvAwKcpfnwY59BIkwsg6q4L2wviqCrgBcIXSobBkRjZAACF2UEPlzclAva3hJqLelD1XQ8U7KAkZOjz3Cico6KWUutcvIh97PNquGUMNEiut-CVqbiZIzUXKGj82MG5RcRt514tk3Tl6MKu-ufhJF2OsnfViu56ZVKONxmgNVoCfHfcErbQUvJTgOOgCAhYwcdgpgWvveGB1T8GU-xi7ovhQNM5622BqWO6wSLxpAiCAy8qLRlv04Ou3LiOzpUW-g_RI0hcT93ar-q_9ueUgeNNviY8bFa3KwXe_gDRls_O4o7Ufg8_vJ76NkU38BHZcnKg |
| link.rule.ids | 108,230,315,729,782,786,866,887,2106,24946,27933,27934,53800,53802,75821,75822 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZoEYIL70IoDx844madXa9tLgjSlqA2BSlF4mZ57XEaqd1EeRz494z3EbpVTz3ueizvah6esWe-IeSjLHBPltozwZVjWchyphQXzOkEOBpMBSEeZY8m8uyPOjyKMDmirYWpkvZdMTsoL68OytlFlVu5uHL9Nk-s_2s8xBAcvWbd3yH3UV-TpA3Sm8uDCNPfAAxxlfc52l-GkY2IWQgTziZpWkEApyiu-c1C98vO_lTB-N_me95Moby2Jx0_uePfPCWPGyeUfq2Hn5F7UD4nD-q2lH9fkM3s-9H48Ofw5DO1tEK0jpyk12ri6Dzg40XE6iintKGmMYd-Shf_wbCraRGQYlmXT6yoLT1dzFdrhtYKI-hIbxtYlJfk9_HR-XDEmvYMrJCJWjMQoLXwMihIXZoGO_DRvYTEOiiC98L6Igu6AHCZ0KGwefSFhARAp0cJke6R3XJewmtCvc19KIKO3SwzSJweeHRECuuklKnUrke-dJhkFjUUh4ng2N0R1FMTOW4ixw0fmAk3yPEe-dSydTu5in9Ufjv5t8j6zjrVi_lyahrmGY8GElSGMSD3GS-0FTyX4DjoAAAWemS_FRzTWIaV0bF4X6YDXIJuR1Gl4z2NLWG-QZLYogCdC9Ejr2op235HK7U9Ijvy1_nQ7giKXYUa3ojZmzvP_EAejs7Hp-b0x9nJPnlUH64PGBdvye56uYF3ZGflN-8rXfwH_3g6rA |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZoEYgL78dSHj5wxN04iWObC4J9UFRaKi1I3CzHHm9XarOrfRz494yT7NJUPcEx8VhONA_P2DPfEPJOlrgnS-2Z4MqxPOQFU4oL5nQCHA2mghCPso8m8vSXGo4iTM6u1VedtO_K2WF1cXlYzc7r3MrFpetv88T6ZycDDMHRa9b9hQ_9PXIbdTZJt4F6e4EQofpbkCGuij5HG8wwuhExE2HC2STLahjgDEW2uF7sftHZo2oo_5v8z-tplFf2pfGD__ijh-R-64zSTw3JI3ILqsfkTtOe8vcTspl9GZ0Mvw-OP1BLa2TryFF6pTaOzgM-nkfMjmpKW2oac-mndPEXFLueFoEplk0ZxYraytPFfLVmaLUwko70toVHeUp-jkc_BkesbdPASpmoNQMBWgsvg4LMZVmwqY9uJiTWQRm8F9aXedAlgMuFDqUtok8kJAA6P0qI7BnZr-YVvCDU28KHMujY1TKHxOnUo0NSWielzKR2PfKxwyizaCA5TATJ7o6gvprIdRO5bnhqJtwg13vk_Za1u8l1HKSKm8k_R_Z31qlfzJdT0zLQeDSUoHKMBbnPeamt4IUEx0EHALDQIwdb4TGthVgZHYv4ZZbiEnQ3iqod72tsBfMNksRWBehkiB553kja7ju2ktsjsiODnQ_tjqDo1ejhrai9_OeZb8nds-HYfPt6enxA7jVn7Cnj4hXZXy838JrsrfzmTa2OfwC2-D0s |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=iGEMDOCK%3A+a+graphical+environment+of+enhancing+GEMDOCK+using+pharmacological+interactions+and+post-screening+analysis&rft.jtitle=BMC+bioinformatics&rft.au=Hsu%2C+Kai-Cheng&rft.au=Chen%2C+Yen-Fu&rft.au=Lin%2C+Shen-Rong&rft.au=Yang%2C+Jinn-Moon&rft.date=2011-02-15&rft.pub=BioMed+Central&rft.eissn=1471-2105&rft.volume=12&rft.issue=Suppl+1&rft.spage=S33&rft_id=info:doi/10.1186%2F1471-2105-12-S1-S33&rft.externalDocID=2501807881 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2105&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2105&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2105&client=summon |